Bank of Montreal Can Trims Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Bank of Montreal Can lowered its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 58.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 22,190 shares of the company's stock after selling 31,175 shares during the period. Bank of Montreal Can's holdings in Option Care Health were worth $515,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in OPCH. Prospector Partners LLC acquired a new stake in shares of Option Care Health in the fourth quarter valued at approximately $2,100,000. Quadrant Capital Group LLC boosted its stake in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares during the last quarter. Wells Fargo & Company MN grew its holdings in shares of Option Care Health by 9.5% in the 4th quarter. Wells Fargo & Company MN now owns 180,391 shares of the company's stock valued at $4,185,000 after acquiring an additional 15,609 shares in the last quarter. Landscape Capital Management L.L.C. increased its position in shares of Option Care Health by 102.3% in the fourth quarter. Landscape Capital Management L.L.C. now owns 29,775 shares of the company's stock valued at $691,000 after acquiring an additional 15,055 shares during the last quarter. Finally, ExodusPoint Capital Management LP boosted its position in Option Care Health by 167.8% during the fourth quarter. ExodusPoint Capital Management LP now owns 54,810 shares of the company's stock valued at $1,272,000 after purchasing an additional 34,340 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Stock Up 0.2 %

Shares of NASDAQ OPCH traded up $0.07 during midday trading on Thursday, hitting $32.18. 1,703,635 shares of the stock traded hands, compared to its average volume of 1,783,722. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The business has a 50 day moving average price of $33.33 and a two-hundred day moving average price of $28.70. The company has a market cap of $5.29 billion, a PE ratio of 27.04, a P/E/G ratio of 2.30 and a beta of 1.07.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. JMP Securities restated a "market outperform" rating and set a $36.00 price objective on shares of Option Care Health in a research report on Tuesday. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a research note on Monday. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Finally, JPMorgan Chase & Co. upped their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $33.75.

Insider Buying and Selling at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is currently owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.